Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON41974Not yet recruiting
Randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Amsterdam UMC. Primary endpoint: Postoperative glucose at 2 hours. Planned start Jul 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON41974.